Measures of 'exposure needed for one additional patient to be harmed' in population-based case-control studies

Pharmacoepidemiology and Drug Safety

Volumn 23, Issue 8, 2014, Pages 868-874

  Hallas, Jesper ^a,b   Christensen, Rene Depont ^a   Stürmer, Til ^c   Pottegård, Anton ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c University of North Carolina at Chapel Hill   (United States)

Author keywords

Case control study; NSAIDs; Pharmacoepidemiology; Risk communication

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG USE; EXPOSURE NEEDED FOR ONE ADDITIONAL PATIENT TO BE HARMED; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PATIENT HARM; PEPTIC ULCER BLEEDING; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; STANDARDIZATION; STATISTICAL ANALYSIS; UPPER GASTROINTESTINAL BLEEDING; AGE; CASE CONTROL STUDY; CHEMICALLY INDUCED; DENMARK; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; PRESCHOOL CHILD; RISK; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DENMARK; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EPIDEMIOLOGIC RESEARCH DESIGN; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; RISK; YOUNG ADULT;

EID: 84904903539     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3635     Document Type: Article

References (24)

1. International Society of Pharmacoepidemiology. Guidelines for good pharmacoepidemiology practice (GPP). Pharmacoepidemiol Drug Saf 2008; 17: 200-208.
2. Sackett DL, Deeks JJ, Altman DG. Down with odds ratios!. Evid Based Med 1996; 1: 164-166.
3. Gigerenzer G, Gaissmaier W, Kurz-Milcke E, Schwartz LM, Woloshin S. Helping doctors and patients to make sense of health statistics. Psychol Sci Public Interest 2007; 8: 53-96.
4. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995; 310: 452-454.
5. Altman DG. Confidence intervals for the number needed to treat. BMJ 1998; 317: 1309-1312.
6. Bjerre LM, LeLorier J. Expressing the magnitude of adverse effects in case-control studies: "the number of patients needed to be treated for one additional patient to be harmed" BMJ 2000; 320: 503-506.
7. Carson JL, Strom BL, Soper KA, West SL, Morse ML. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 1987; 147: 85-88.
8. Lassen A, Hallas J. Schaffalitzky de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol 2006; 101: 945-953.
9. Dall M, Schaffalitzky de Muckadell OB, Lassen AT, Hansen JM, Hallas J. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin Gastroenterol Hepatol 2009; 7: 1314-1321.
10. Gaist D, Sørensen HT, Hallas J. The Danish prescription registers. Dan Med Bull 1997; 44: 445-448.
11. www.medstat.dk [22 April 2014]
12. Hallas J, Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and the risk of serious upper gastrointestinal bleeding. A nested case-control study. BMJ 2006; 333: 726-730.
13. Rothman KJ. Epidemiology - an introduction. Oxford University Press: Oxford, England, 2002. p. 53.
14. www.dst.dk [22 April 2014]
15. Haukoos JS, Lewis RJ. Advanced Statistics: Bootstrapping Confidence Intervals for Statistics with "Difficult" Distributions. Acad Emerg Med 2005; 12(4): 360-365.
16. Thygesen LC, Daasnes C, Thaulow I, Brønnum-Hansen H. Introduction to Danish (nationwide) Registers on Health and Social Issues: Structure, Access, Legislation, and Archiving. Scand J Publ Health 2011; 39(Suppl 7): 12-16.
17. Essebag V, Platt RW, Abrahamowicz M, Pilote L. Comparison of nested case control and survival analysis methodologies for analysis of time-dependent exposure. BMC Med Res Methodol 2005; 5-10.
18. Essebag V, Genest J, Jr, Suissa S, Pilote L. The nested case-control study in cardiology. Am Heart J 2003; 146: 581-590.
19. Stürmer T, Rothman KJ, Glynn RJ. Insights into Different Results from Different Causal Contrasts in the Presence of Effect-Measure Modification. Pharmacoepidemiol Drug Saf 2006; 15: 698-709.
20. Hallas J, Lauritsen J, Villadsen HD, Gram LF. NSAID and upper gastrointestinal bleeding, identifying high-risk groups by excess risk estimates. Scand J Gastroenterol 1995; 30: 438-444.
21. Hernández-Díaz S, Rodríguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000; 160: 2093-2099.
22. Rothman KJ, Poole C. A strengthening programme for weak associations. Int J Epidemiol 1988; 17: 955-959.
23. Christensen PM, Brosen K, Brixen K, Andersen M, Kristiansen IS. A randomized trial of laypersons' perception of the benefit of osteoporosis therapy: number needed to treat versus postponement of hip fracture. Clin Ther 2003 Oct; 25(10): 2575-2585.
24. Halvorsen PA, Kristiansen IS. Decisions on drug therapies by numbers needed to treat: a randomized trial. Arch Intern Med 2005; 165: 1140-1146.